RENEE BURKHART: Open Payments
NPI 1003273178 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$109 in 6 payments from 4 companies in 2025. Trend: 2023 $199 · 2024 $277 · 2025 $109
Food & beverage: $109
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $45 |
| ABBVIE INC. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Veozah, LINZESS, REXULTI, SHINGRIX.
Industry payments across IN — which companies pay providers there.
